The Technology and Life Sciences practice of Goodwin France brought on Guilhem Richard, partner in Goodwin’s Life Sciences and Technology groups. Guilhem has worked on significant transactions, including Abivax's Nasdaq listing and capital increases for various companies, such as €102.9 million for Valneva, €52 million for Waga Energy, and €50.5 million for Sensorion. In each instance, he served as an advisor to the listing sponsors. Guilhem also provides guidance to listed companies and their boards on financing strategies, as well as daily matters concerning corporate and securities law and corporate governance. With Guilhem's arrival, Goodwin's Technology and Life Sciences France team comprises 20 lawyers. For more information on Goodwin’s expansion, read the article on CFNEWS.